trending Market Intelligence /marketintelligence/en/news-insights/trending/S958XPAK8wBzXdAUfdGZ8g2 content esgSubNav
In This List

Ampersand Capital Partners to buy Vibalogics

Podcast

Street Talk | Episode 94: Recessionary fears in ’22 overblown, Fed could overtighten

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Ampersand Capital Partners to buy Vibalogics

Middle-market private equity firm Ampersand Capital Partners is acquiring Vibalogics Gmbh for an undisclosed amount.

Vibalogics provides process development, manufacturing, and fill and finish of products for biopharmaceutical companies developing oncolytic viral therapies, gene therapies and vaccines.